Engineered Protease Polypeptides for PEI Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pancreatic replacement therapies for pancreatic exocrine insufficiency (PEI/EPI) are inadequate due to insufficient enzyme activity in the gastrointestinal tract and high pill burden, leading to malabsorption issues and health concerns.
Innovation Solution
Engineered protease polypeptides with enhanced expression, proteolytic activity, thermostability, resistance to gastric proteases, and stability at acidic pH, designed to improve digestion efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If pancreatic replacement therapy is administered to PEI/EPI patients, then digestive enzyme supply is improved, but pill burden increases significantly
Solution Approach 1:
The patent combines multiple digestive enzymes (amylase, lipase, and protease) into a single therapeutic composition, eliminating the need for multiple separate pills while maintaining comprehensive digestive enzyme supply for PEI/EPI patients
2Reliability
If current PERT enzymes are administered, then some digestive function is restored, but enzyme activity in the gastrointestinal tract remains insufficient
Solution Approach 1:
The patent employs engineered proteases with modified amino acid sequences that exhibit enhanced proteolytic activity and improved stability at gastrointestinal pH levels, thereby increasing effective enzyme activity where it is needed most
Solution Approach 2:
The engineered proteases are designed with specific properties optimized for the gastrointestinal environment, including pH stability and resistance to gastric proteases, ensuring reliable performance in the specific location of the gastrointestinal tract
3Reliability
If natural protease is used in PERT, then basic proteolytic function is provided, but resistance against gastric proteases and stability at acidic pH are insufficient
Solution Approach 1:
The protease is engineered with specific amino acid substitutions that enhance its structural stability at acidic pH levels and increase its resistance to degradation by gastric proteases, while maintaining catalytic activity
Solution Approach 2:
The patent creates an engineered protease variant that combines the catalytic functionality of natural protease with enhanced stability properties, effectively creating a composite enzyme with multiple optimized characteristics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered protease polypeptides effectively enhance digestion in PEI/EPI patients by improving enzyme activity and stability, addressing the limitations of existing therapies.
Implementation Method 1
the present disclosure provides engineered protease polypeptides, recombinant polynucleotides encoding the engineered protease polypeptides, and uses of the engineered protease polypeptides for degrading target proteins and polypeptides
Data Source
AI summary
The present disclosure provides engineered protease polypeptides, recombinant polynucleotides encoding the engineered protease polypeptides, and uses of the engineered protease polypeptides in therapeutic applications.